Human carbonic anhydrase IX (hCA IX) expression in many cancers is associated with hypoxic tumors and poor patient outcome. Inhibitors of hCA IX have been used as anticancer agents with some entering Phase I clinical trials. hCA IX is transmembrane protein whose catalytic domain faces the extracellular tumor milieu, which is typically associated with an acidic microenvironment. Here, we show that the catalytic domain of hCA IX (hCA IX-c) exhibits the necessary biochemical and biophysical properties that allow for low pH stability and activity. Furthermore, the unfolding process of hCA IX-c appears to be reversible, and its catalytic efficiency is thought to be correlated directly with its stability between pH 3.0 and 8.0 but not above pH 8.0. To rationalize this, we determined the X-ray crystal structure of hCA IX-c to 1.6 Å resolution. Insights from this study suggest an understanding of hCA IX-c stability and activity in low-pH tumor microenvironments and may be applicable to determining pH-related effects on enzymes.
Humann class="Gene">carbonic anhydrase IX (hCA IX) expression in many cancers is associated with hypoxic tumors and poor patient outcome. Inhibitors of hCA IX have been used as anticancer agents with some entering Phase I clinical trials. hCA IX is transmembrane protein whose catalytic domain faces the extracellular tumor milieu, which is typically associated with an acidic microenvironment. Here, we show that the catalytic domain of hCA IX (hCA IX-c) exhibits the necessary biochemical and biophysical properties that allow for low pH stability and activity. Furthermore, the unfolding process of hCA IX-c appears to be reversible, and its catalytic efficiency is thought to be correlated directly with its stability between pH 3.0 and 8.0 but not above pH 8.0. To rationalize this, we determined the X-ray crystal structure of hCA IX-c to 1.6 Å resolution. Insights from this study suggest an understanding of hCA IX-c stability and activity in low-pH tumor microenvironments and may be applicable to determining pH-related effects on enzymes.
Authors: John F Domsic; Balendu Sankara Avvaru; Chae Un Kim; Sol M Gruner; Mavis Agbandje-McKenna; David N Silverman; Robert McKenna Journal: J Biol Chem Date: 2008-09-02 Impact factor: 5.157
Authors: Carrie L Lomelino; Brian P Mahon; Robert McKenna; Fabrizio Carta; Claudiu T Supuran Journal: Bioorg Med Chem Date: 2016-01-11 Impact factor: 3.641
Authors: Vincenzo Alterio; Mika Hilvo; Anna Di Fiore; Claudiu T Supuran; Peiwen Pan; Seppo Parkkila; Andrea Scaloni; Jaromir Pastorek; Silvia Pastorekova; Carlo Pedone; Andrea Scozzafava; Simona Maria Monti; Giuseppina De Simone Journal: Proc Natl Acad Sci U S A Date: 2009-09-14 Impact factor: 11.205
Authors: Somayeh Jamali; Michael Klier; Samantha Ames; L Felipe Barros; Robert McKenna; Joachim W Deitmer; Holger M Becker Journal: Sci Rep Date: 2015-09-04 Impact factor: 4.379
Authors: Airlie J McCoy; Ralf W Grosse-Kunstleve; Paul D Adams; Martyn D Winn; Laurent C Storoni; Randy J Read Journal: J Appl Crystallogr Date: 2007-07-13 Impact factor: 3.304
Authors: Shonagh Russell; Liping Xu; Yoonseok Kam; Dominique Abrahams; Bryce Ordway; Alex S Lopez; Marilyn M Bui; Joseph Johnson; Tamir Epstein; Epifanio Ruiz; Mark C Lloyd; Pawel Swietach; Daniel Verduzco; Jonathan Wojtkowiak; Robert J Gillies Journal: BMC Biol Date: 2022-07-15 Impact factor: 7.364
Authors: Zhijuan Chen; Lingbao Ai; Mam Y Mboge; Chingkuang Tu; Robert McKenna; Kevin D Brown; Coy D Heldermon; Susan C Frost Journal: PLoS One Date: 2018-07-02 Impact factor: 3.240